SM
AGN

Scoggin Management’s Allergan plc AGN Stock Holding History

Scoggin Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-24,000
Closed -$5.04M – 66
2016
Q4 		$5.04M Sell
24,000
-24,000
-50% -$4.97M 0.68% 35
2016
Q3 		$11.1M Sell
48,000
-50,700
-51% -$12.4M 1.9% 16
2016
Q2 		$22.8M Sell
98,700
-4,300
-4% -$991K 2.56% 10
2016
Q1 		$27.6M Sell
103,000
-25,500
-20% -$7.3M 2.92% 9
2015
Q4 		$40.2M Buy
128,500
+80,000
+165% +$23.8M 5.95% 3
2015
Q3 		$13.2M Sell
48,500
-73,400
-60% -$22.5M 3.03% 11
2015
Q2 		$37M Buy
+121,900
New +$36.4M 3.22% 6
2015
Q1 		– Sell
-28,200
Closed -$7.26M – 135
2014
Q4 		$7.26M Sell
28,200
-69,300
-71% -$17.3M 0.66% 33
2014
Q3 		$23.5M Buy
97,500
+87,500
+875% +$19.6M 1.25% 19
2014
Q2 		$2.23M Sell
10,000
-76,700
-88% -$15.9M 0.13% 67
2014
Q1 		$17.8M Buy
+86,700
New +$17.2M 1.69% 15
2013
Q3 		– Sell
-96,000
Closed -$12.1M – 123
2013
Q2 		$12.1M Buy
+96,000
New +$10.9M 1.41% 28

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Scoggin Management's AGN Position: Q1 2017 in Review

Scoggin Management sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 24,000 shares — an estimated $5.04M sold.

Scoggin Management first reported a position in AGN in Q2 2013 and held it in 12 quarters. The position peaked at $40.2M in Q4 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Scoggin Management reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Scoggin Management sold 24,000 Allergan plc shares in Q1 2017, an estimated $5.04M.
  • Scoggin Management first reported a position in Allergan plc in Q2 2013 and held it in 12 quarters.
  • Scoggin Management's Allergan plc position peaked at $40.2M in Q4 2015.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Scoggin Management's 13F filing for Q1 2017, filed 12 May 2017.